At its Annual Meeting of Stockholders on June 9, 2026, Cabaletta Bio, Inc. stockholders approved an amendment to the company's Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 600,000,000. The company filed a Certificate of Amendment with the State of Delaware on the same day. Cabaletta Bio, Inc. is a biotechnology company focused on cell and gene therapy.